0001209191-21-032974.txt : 20210514
0001209191-21-032974.hdr.sgml : 20210514
20210514200934
ACCESSION NUMBER: 0001209191-21-032974
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210504
FILED AS OF DATE: 20210514
DATE AS OF CHANGE: 20210514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Viney Joanne L.
CENTRAL INDEX KEY: 0001816744
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38800
FILM NUMBER: 21927008
MAIL ADDRESS:
STREET 1: C/O HARPOON THERAPEUTICS, INC.
STREET 2: 131 OYSTER POINT BOULEVARD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708493
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473458693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-443-7400
MAIL ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-05-04
2021-05-07
0
0001708493
Harpoon Therapeutics, Inc.
HARP
0001816744
Viney Joanne L.
C/O HARPOON THERAPEUTICS, INC.
131 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Director Stock Option (Right to Buy)
23.20
2021-05-04
4
A
0
10167
0.00
A
2031-05-03
Common Stock
10167
10167
D
Director Stock Option (Right to Buy)
23.20
2021-05-04
4
A
0
2571
0.00
A
2031-05-03
Common Stock
2571
2571
D
This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error.
The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022.
This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value.
The number of shares underlying the option was erroneously reported as 2,653 on the original Form 4 filed on May 7, 2021 due to an administrative error related to the calculation date of the Black-Scholes value.
50% of the shares subject to the option are fully vested and exercisable, and 25% will vest and become exercisable on September 30, 2021 and December 31, 2021, subject to the continuous service of the Reporting Person on each vesting date.
/s/ Joanne L. Viney by Christopher Whitmore, Attorney-in-Fact
2021-05-14